Adma Biologics (ADMA) Treasury Shares (2013 - 2025)

Adma Biologics has reported Treasury Shares for 1 years, with the latest figure at $32.1 million in Q4 2025.

• For the quarter ending Q3 2025, Treasury Shares changed N/A year-over-year to $5.2 million; the trailing twelve-month figure through Sep 2025 stood at $5.2 million (changed N/A YoY), and the FY2024 full-year result was $5.7 million, down 54.04% from the prior year.
• Treasury Shares for Q3 2025 stood at $5.2 million, up from $816000.0 in the prior quarter.
• The five-year high for Treasury Shares was $13.5 million in Q4 2022, with the low at $686133.0 in Q2 2021.
• Historically, Treasury Shares has averaged $5.3 million across 5 years, with a median of $4.8 million in 2023.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 591.18% — and 2025, when it slumped 73.87%.
• Adma Biologics' Treasury Shares stood at $4.5 million in 2021, then soared by 198.69% to $13.5 million in 2022, then retreated by 7.56% to $12.5 million in 2023, then tumbled by 54.04% to $5.7 million in 2024, then decreased by 9.01% to $5.2 million in 2025.
• The last three Treasury Shares figures came in at $32.1 million (Q4 2025), $23.2 million (Q3 2025), and $15.1 million (Q2 2025), per Business Quant data.